Donald W. DeGolyer, Director at Emergent BioSolutions Inc. (EBS), sold 15,481 shares at $8.36 ($130K) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Scheduled sale ($130k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.36 | 14,527 | $121K | 93.4% |
| 2 | $8.96 | 954 | $9K | 6.6% |
| Total | $8.40 avg | 15,481 | $130K | 100% |
| Filing → |
| EBS | SELL | 2025-08-13 | $136K | — | Filing → |
| EBS | SELL | 2024-11-14 | $273K | — | Filing → |